Basement membrane antibodies in sera of haematopoietic cell recipients are associated with graft-versus-host disease

Journal of the European Academy of Dermatology and Venereology

Volumn 24, Issue 5, 2010, Pages 587-594

  Hofmann, S C ^a   Kopp, G ^a   Gall, C ^a   Bruckner Tuderman, L ^a   Bertz, H ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Antibodies; Bullous pemphigoid; Cutaneous basement membrane; Epidermolysis bullosa acquisita; Graft versus host disease

Indexed keywords

BASEMENT MEMBRANE ANTIBODY; BULLOUS PEMPHIGOID ANTIGEN 1; COLLAGEN TYPE 17; COLLAGEN TYPE 7; CORTICOSTEROID; CUTANEOUS BASEMENT MEMBRANE ANTIBODY; CYCLOSPORIN A; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; KALININ; LAMININ; LAMININ ALPHA1; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB; TACROLIMUS; UNCLASSIFIED DRUG; AUTOANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; AGED; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; B CELL LYMPHOMA; BLISTER; BULLOUS PEMPHIGOID; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMOLYSIS BULLOSA ACQUISITA; ERYTHEMA; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; LEUKEMIA; MALE; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NEUROPATHY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PRURITUS; PSORIASIS; XEROSTOMIA; BASEMENT MEMBRANE; BLOOD; CASE CONTROL STUDY; IMMUNOLOGY; PROSPECTIVE STUDY;

AUTOANTIBODIES; BASEMENT MEMBRANE; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; PROSPECTIVE STUDIES;

EID: 77950856365     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2009.03480.x     Document Type: Article

References (40)

1. Hausermann P, Walter RB, Halter J et al. Cutaneous graft-versus-host disease: a guide for the dermatologist. Dermatology 2008 216 : 287 304.
2. Mielcarek M, Martin PJ, Leisenring W et al. Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood 2003 102 : 756 762.
3. Gilliam AC. Update on graft versus host disease. J Invest Dermatol 2004 123 : 251 257.
4. Bertz H, Potthoff K, Finke J. Allogeneic stem-cell transplantation from related and unrelated donors in older patients with myeloid leukemia. J Clin Oncol 2003 21 : 1480 1484.
5. Filipovich AH, Weisdorf D, Pavletic S et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005 11 : 945 956. (Pubitemid 41754712)
6. Hymes SR, Turner ML, Champlin RE et al. Cutaneous manifestations of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2006 12 : 1101 1113.
7. Izumi R, Fujimoto M, Yazawa N et al. Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease. J Am Acad Dermatol 2007 56 : S94 S97.
8. Hofmann SC, Voith U, Schonau V et al. Plasmin Plays a Role in the In Vitro Generation of the Linear IgA Dermatosis Antigen LADB97. J Invest Dermatol 2009 129 : 1730 1739.
9. Hofmann S, Thoma-Uszynski S, Hunziker T et al. Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain. J Invest Dermatol 2002 119 : 1065 1073.
10. Dainichi T, Kurono S, Ohyama B et al. Anti-laminin gamma-1 pemphigoid. Proc Natl Acad Sci USA 2009 106 : 2800 2805.
11. Hofmann SC, Voith U, Sasaki T et al. The autoantigen in anti-p200 pemphigoid is synthesized by keratinocytes and fibroblasts and is distinct from nidogen-2. J Invest Dermatol 2008 128 : 87 95.
12. Rouquette-Gally AM, Boyeldieu D, Prost AC et al. Autoimmunity after allogeneic bone marrow transplantation. A study of 53 long-term-surviving patients. Transplantation 1988 46 : 238 240.
13. Sherer Y, Shoenfeld Y. Autoimmune diseases and autoimmunity post-bone marrow transplantation. Bone Marrow Transplant 1998 22 : 873 881. (Pubitemid 28499360)
14. Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980 69 : 204 217.
15. Tsoi MS, Storb R, Jones E et al. Deposition of IgM and complement at the dermoepidermal junction in acute and chronic cutaneous graft-vs-host disease in man. J Immunol 1978 120 : 1485 1492.
16. Saurat JH, Bonnetblanc JM, Gluckman E et al. Skin antibodies in bone marrow transplanted patients. Clin Exp Dermatol 1976 1 : 377 384.
17. Saurat JH. Cutaneous manifestations of graft-versus-host disease. Int J Dermatol 1981 20 : 249 256.
18. Dreno B, Milpied N, Harousseau JL et al. Cutaneous immunological studies in diagnosis of acute graft-versus-host disease. Br J Dermatol 1986 114 : 7 15.
19. Schultewolter T, Goos M, Dissemond J. Linear IgA dermatosis in an immunosuppressed patient after allogenic bone marrow transplantation. J Eur Acad Dermatol Venereol 2004 18 : 721 725.
20. Ueda M, Mori T, Shiobara S et al. Development of bullous pemphigoid after allogeneic bone marrow transplantation. Report of a case. Transplantation 1986 42 : 320 322. (Pubitemid 16020763)
21. Patriarca F, Skert C, Sperotto A et al. The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft-vs-host disease and immune recovery. Exp Hematol 2006 34 : 389 396.
22. Rieckhoff-Cantoni L, Bernard P, Didierjean L et al. Frequency of bullous pemphigoid-like antibodies as detected by western immunoblot analysis in pruritic dermatoses. Arch Dermatol 1992 128 : 791 794.
23. Hofmann SC, Otto C, Bruckner-Tuderman L et al. Isolated NC16a-ELISA testing is of little value to identify bullous pemphigoid in elderly patients with chronic pruritus. Eur J Dermatol 2009 (in press).
24. Cooper SM, Dean D, Allen J et al. Erosive lichen planus of the vulva: weak circulating basement membrane zone antibodies are present. Clin Exp Dermatol 2005 30 : 551 556.
25. Waters AH, Metcalfe P, Minchinton RM et al. Autoimmune thrombocytopenia acquired from allogeneic bone-marrow graft: compensated thrombocytopenia in bone marrow donor and recipient. Lancet 1983 2 : 1430.
26. Amagai M, Hashimoto T, Green KJ et al. Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus. J Invest Dermatol 1995 104 : 895 901.
27. Canninga-van Dijk MR, van der Straaten HM, Fijnheer R et al. Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease. Blood 2004 104 : 2603 2606.
28. Schmidt E, Hunzelmann N, Zillikens D et al. Rituximab in refractory autoimmune bullous diseases. Clin Exp Dermatol 2006 31 : 503 508.
29. Szabolcs P, Reese M, Yancey KB et al. Combination treatment of bullous pemphigoid with anti-CD20 and anti-CD25 antibodies in a patient with chronic graft-versus-host disease. Bone Marrow Transplant 2002 30 : 327 329.
30. Daikeler T, Tyndall A. Autoimmunity following haematopoietic stem-cell transplantation. Best Pract Res Clin Haematol 2007 20 : 349 360.
31. Chen X, Vodanovic-Jankovic S, Johnson B et al. Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease. Blood 2007 110 : 3804 3813.
32. Sitaru C, Powell J, Messer G et al. Immunoblotting and enzyme-linked immunosorbent assay for the diagnosis of pemphigoid gestationis. Obstet Gynecol 2004 103 : 757 763.
33. Lacour JP, Adrien A, Gratecos N, et al. Bullous pemphigoid following graft-versus-host reaction after bone marrow allograft. Presse Med 1988 17 : 1367 1368.
34. Burger J, Gmür J, Bruckner-Tuderman L. Epidermolysis bullosa acquisita, a rare late complication of allogeneic bone marrow transplantation? Bone Marrow Transplant 1992 9 : 139 141.
35. Delbaldo C, Rieckhoff-Cantoni L, Helg C, et al. Bullous pemphigoid associated with acute graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 1992 10 : 377 379.
36. Kikuchi A, Kawahara Y, Okamoto S, et al. Tense blisters after bone marrow transplantation. Arch Dermatol 1999 135 : 81 86.
37. Nagai H, Shirakata Y, Midorikawa K, et al. A case of bullous pemphigoid associated with graft-versus-host disease. Nishinihon J Dermatol 2004 66 : 269 273.
38. Kawasuji A, Matsushita Y, Oishi N, et al. Bullous pemphigoid after allogeneic bone marrow transplantation. Jpn J Clin Dermatol 2004 46 : 1823 1826.
39. Herr AL, Hatami A, Kokta V, et al. Successful anti-CD20 antibody treatment of pemphigus foliaceus after unrelated cord blood transplantation. Bone Marrow Transplant 2005 35 : 427 428.
40. Aisa Y, Mori T, Nakazato T, et al. Cicatricial pemphigoid of the oropharynx after allogeneic stem cell transplantation for relapsed follicular lymphoma. Int J Hematol 2005 82 : 266 269.